Milestone Pharmaceuticals Inc. (MIST) Misses Q4 EPS by 3c

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q4 EPS of ($0.19), $0.03 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• OpenAI launches cybersecurity tools and open-source patching program
• Bending Spoons valuation up to $19 Billion in U.S. IPO - Reuters